Enter a Search String |
| Special character and space not allowed in the query term. Search string should be at least 2 characters long. |
Molecule Parameter List for PKA-active | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| The statistics table lists the distribution of a molecule acting either as a substrate, product, enzyme or as a molecule within the network. The text color of a molecule is highlighted by color. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Statistics | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| PKA-active participated as | Molecule | Sum total of | Enzyme | Substrate of an enzyme | Product of an enzyme | Substrate in Reaction | Product in Reaction |
| No. of occurrences | 1 | 0 | 35 | 0 | 0 | 1 | 2 |
Accession and Pathway Details |
| Accession Name | Accession No. | Accession Type | Pathway Link |
weak_coupling | 65 | Network | Shared_Object_AMPAR_CaMKII_weak_coupling, CaMKII, CaM, PP1, PP2B, PP1_PSD, AMPAR, PKA, AC, AMPAR_memb, PP1_CaMKII_PSD, CaMKII_PSD |
| This is a model of weak coupling between the AMPAR traffikcing bistability, and the CaMKII autophosphorylation bistability. In this model, there are three stable states: Both off, AMPAR on, or both on. The fourth possible state: CaMKII on but AMPAR off, is not truly stable, since over the course of hours the AMPAR also turns on. | |||
PKA-active acting as a Molecule in AMPAR_CaMKII_weak_coupling Network
| Name | Accession Name | Pathway Name | Initial Conc. (uM) | Volume (fL) | Buffered | |
| PKA-active | weak_coupling Accession No. : 65 | PKA Pathway No. : 288 | 0 | 0.09 | No | |
PKA-active acting as an Enzyme in AMPAR_CaMKII_weak_coupling Network
| Enzyme Molecule / Enzyme Activity | Accession Name | Pathway Name | Km (uM) | kcat (s^-1) | Ratio | Enzyme Type | Reagents | |
| 1 | PKA-active / phosph-PDE | weak_coupling Accession No. : 65 | PKA Pathway No. : 288 | 7.50008 | 9 | 4 | explicit E-S complex | Substrate cAMP-PDE Product cAMP-PDE* |
| Same rates as PKA-phosph-I1 | ||||||||
| 2 | PKA-active / PKA-phosph-I1 | weak_coupling Accession No. : 65 | PKA Pathway No. : 288 | 7.50008 | 9 | 4 | explicit E-S complex | Substrate I1 Product I1* |
| #s from Bramson et al CRC crit rev Biochem 15:2 93-124. They have a huge list of peptide substrates and I have chosen high-ish rates. These consts give too much PKA activity, so lower Vmax 1/3. Now, k1 = 3e-5, k2 = 36, k3 = 9 (still pretty fast). Also lower Km 1/3 so k1 = 1e-5 Cohen et al FEBS Lett 76:182-86 1977 say rate =30% PKA act on phosphokinase beta. | ||||||||
| 3 | PKA-active / PSD | weak_coupling Accession No. : 65 | PKA Pathway No. : 288 | 7.50008 | 9 | 4 | explicit E-S complex | Substrate I1 Product I1* |
| 4 | PKA-active / PKA[17] | weak_coupling Accession No. : 65 | PKA Pathway No. : 288 | 7.50021 | 6 | 4 | explicit E-S complex | Substrate A_B Product A845*_B |
| 5 | PKA-active / PKA[16] | weak_coupling Accession No. : 65 | PKA Pathway No. : 288 | 7.50021 | 6 | 4 | explicit E-S complex | Substrate A831*_B Product A831*845*_B |
| 6 | PKA-active / PKA[18] | weak_coupling Accession No. : 65 | PKA Pathway No. : 288 | 7.50021 | 6 | 4 | explicit E-S complex | Substrate A_B831* Product A845*_B831* |
| 7 | PKA-active / PKA[19] | weak_coupling Accession No. : 65 | PKA Pathway No. : 288 | 7.50021 | 6 | 4 | explicit E-S complex | Substrate A831*_B831* Product A831*845*_B831* |
| 8 | PKA-active / PKA[20] | weak_coupling Accession No. : 65 | PKA Pathway No. : 288 | 7.50021 | 6 | 4 | explicit E-S complex | Substrate A_B Product A_B845* |
| 9 | PKA-active / PKA[21] | weak_coupling Accession No. : 65 | PKA Pathway No. : 288 | 7.50021 | 6 | 4 | explicit E-S complex | Substrate A831*_B Product A831*_B845* |
| 10 | PKA-active / PKA[22] | weak_coupling Accession No. : 65 | PKA Pathway No. : 288 | 7.50021 | 6 | 4 | explicit E-S complex | Substrate A_B831* Product A_B831*845* |
| 11 | PKA-active / PKA[23] | weak_coupling Accession No. : 65 | PKA Pathway No. : 288 | 7.50021 | 6 | 4 | explicit E-S complex | Substrate A831*_B831* Product A831*_B831*845* |
| 12 | PKA-active / PKA[24] | weak_coupling Accession No. : 65 | PKA Pathway No. : 288 | 7.50021 | 6 | 4 | explicit E-S complex | Substrate A_B845* Product A845*_B845* |
| 13 | PKA-active / PKA[25] | weak_coupling Accession No. : 65 | PKA Pathway No. : 288 | 7.50021 | 6 | 4 | explicit E-S complex | Substrate A831*_B845* Product A831*845*_B845* |
| 14 | PKA-active / PKA[26] | weak_coupling Accession No. : 65 | PKA Pathway No. : 288 | 7.50021 | 6 | 4 | explicit E-S complex | Substrate A_B831*845* Product A845*_B831*845* |
| 15 | PKA-active / PKA[27] | weak_coupling Accession No. : 65 | PKA Pathway No. : 288 | 7.50021 | 6 | 4 | explicit E-S complex | Substrate A831*_B831*845* Product B835*845* |
| 16 | PKA-active / PKA[28] | weak_coupling Accession No. : 65 | PKA Pathway No. : 288 | 7.50021 | 6 | 4 | explicit E-S complex | Substrate A845*_B Product A845*_B845* |
| 17 | PKA-active / PKA[29] | weak_coupling Accession No. : 65 | PKA Pathway No. : 288 | 7.50021 | 6 | 4 | explicit E-S complex | Substrate A831*845*_B Product A831*845*_B845* |
| 18 | PKA-active / PKA[30] | weak_coupling Accession No. : 65 | PKA Pathway No. : 288 | 7.50021 | 6 | 4 | explicit E-S complex | Substrate A845*_B831* Product A845*_B831*845* |
| 19 | PKA-active / PKA[31] | weak_coupling Accession No. : 65 | PKA Pathway No. : 288 | 7.50021 | 6 | 4 | explicit E-S complex | Substrate A831*845*_B831* Product B835*845* |
| 20 | PKA-active / PKA | weak_coupling Accession No. : 65 | PKA Pathway No. : 288 | 7.50021 | 6 | 4 | explicit E-S complex | Substrate A_B845* Product A845*_B845* |
| 21 | PKA-active / PKA[1] | weak_coupling Accession No. : 65 | PKA Pathway No. : 288 | 7.50021 | 6 | 4 | explicit E-S complex | Substrate A845*_B Product A845*_B845* |
| 22 | PKA-active / PKA[2] | weak_coupling Accession No. : 65 | PKA Pathway No. : 288 | 7.50021 | 6 | 4 | explicit E-S complex | Substrate A_B Product A845*_B |
| 23 | PKA-active / PKA[3] | weak_coupling Accession No. : 65 | PKA Pathway No. : 288 | 7.50021 | 6 | 4 | explicit E-S complex | Substrate A_B Product A_B845* |
| 24 | PKA-active / PKA[4] | weak_coupling Accession No. : 65 | PKA Pathway No. : 288 | 7.50021 | 6 | 4 | explicit E-S complex | Substrate A831*_B845* Product A831*845*_B845* |
| 25 | PKA-active / PKA[5] | weak_coupling Accession No. : 65 | PKA Pathway No. : 288 | 7.50021 | 6 | 4 | explicit E-S complex | Substrate A831*845*_B Product A831*845*_B845* |
| 26 | PKA-active / PKA[6] | weak_coupling Accession No. : 65 | PKA Pathway No. : 288 | 7.50021 | 6 | 4 | explicit E-S complex | Substrate A831*_B Product A831*_B845* |
| 27 | PKA-active / PKA[7] | weak_coupling Accession No. : 65 | PKA Pathway No. : 288 | 7.50021 | 6 | 4 | explicit E-S complex | Substrate A831*_B Product A831*845*_B |
| 28 | PKA-active / PKA[8] | weak_coupling Accession No. : 65 | PKA Pathway No. : 288 | 7.50021 | 6 | 4 | explicit E-S complex | Substrate A_B831*845* Product A845*_B831*845* |
| 29 | PKA-active / PKA[9] | weak_coupling Accession No. : 65 | PKA Pathway No. : 288 | 7.50021 | 6 | 4 | explicit E-S complex | Substrate A845*_B831* Product A845*_B831*845* |
| 30 | PKA-active / PKA[10] | weak_coupling Accession No. : 65 | PKA Pathway No. : 288 | 7.50021 | 6 | 4 | explicit E-S complex | Substrate A_B831* Product A_B831*845* |
| 31 | PKA-active / PKA[11] | weak_coupling Accession No. : 65 | PKA Pathway No. : 288 | 7.50021 | 6 | 4 | explicit E-S complex | Substrate A_B831* Product A845*_B831* |
| 32 | PKA-active / PKA[12] | weak_coupling Accession No. : 65 | PKA Pathway No. : 288 | 7.50021 | 6 | 4 | explicit E-S complex | Substrate A831*_B831*845* Product B835*845* |
| 33 | PKA-active / PKA[13] | weak_coupling Accession No. : 65 | PKA Pathway No. : 288 | 7.50021 | 6 | 4 | explicit E-S complex | Substrate A831*845*_B831* Product B835*845* |
| 34 | PKA-active / PKA[14] | weak_coupling Accession No. : 65 | PKA Pathway No. : 288 | 7.50021 | 6 | 4 | explicit E-S complex | Substrate A831*_B831* Product A831*_B831*845* |
| 35 | PKA-active / PKA[15] | weak_coupling Accession No. : 65 | PKA Pathway No. : 288 | 7.50021 | 6 | 4 | explicit E-S complex | Substrate A831*_B831* Product A831*845*_B831* |
PKA-active acting as a Substrate in a reaction in AMPAR_CaMKII_weak_coupling Network
| Kd is calculated only for second order reactions, like nA+nB <->nC or nA<->nC+nD, where n is number and A,B,C,D are molecules, where as for first order reactions Keq is calculated. Kd for higher order reaction are not consider. |
| Name | Accession Name | Pathway Name | Kf | Kb | Kd | tau | Reagents |
| inhib-PKA | weak_coupling Accession No. : 65 | PKA Pathway No. : 288 | 59.9994 (uM^-1 s^-1) | 1 (s^-1) | Kd(bf) = 0.0167(uM) | - | Substrate PKA-active PKA-inhibitor Product inhibited-PKA |
| This has to be set to zero for matching the expts in vitro. In vivo we need to consider the inhibition though. kf = 1e-5 kb = 1 | |||||||
PKA-active acting as a Product in a reaction in AMPAR_CaMKII_weak_coupling Network
| Kd is calculated only for second order reactions, like nA+nB <->nC or nA<->nC+nD, where n is number and A,B,C,D are molecules, where as for first order reactions Keq is calculated. Kd for higher order reaction are not consider. |
| Name | Accession Name | Pathway Name | Kf | Kb | Kd | tau | Reagents | |
| 1 | Release-C1 | weak_coupling Accession No. : 65 | PKA Pathway No. : 288 | 60 (s^-1) | 17.9998 (uM^-1 s^-1) | Kd(cb) = 0.3(uM) | - | Substrate R2C2-cAMP4 Product PKA-active R2C-cAMP4 |
| This has to be fast, as the activation of PKA by cAMP is also fast. kf was 10 | ||||||||
| 2 | Release-C2 | weak_coupling Accession No. : 65 | PKA Pathway No. : 288 | 60 (s^-1) | 17.9998 (uM^-1 s^-1) | Kd(cb) = 0.3(uM) | - | Substrate R2C-cAMP4 Product PKA-active R2-cAMP4 |
color.